Xiangpeng Dai

1.0k total citations
44 papers, 629 citations indexed

About

Xiangpeng Dai is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Xiangpeng Dai has authored 44 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in Xiangpeng Dai's work include Reproductive Biology and Fertility (13 papers), Pluripotent Stem Cells Research (9 papers) and CRISPR and Genetic Engineering (7 papers). Xiangpeng Dai is often cited by papers focused on Reproductive Biology and Fertility (13 papers), Pluripotent Stem Cells Research (9 papers) and CRISPR and Genetic Engineering (7 papers). Xiangpeng Dai collaborates with scholars based in China, Saint Kitts and Nevis and United States. Xiangpeng Dai's co-authors include Ziyi Li, Yanhui Zhai, Meng Zhang, Xiaoling Zhang, Sheng Zhang, Qi Zhou, Luyao Wang, Yurong Chen, Fucheng Guo and Xinglan An and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiangpeng Dai

43 papers receiving 620 citations

Peers

Xiangpeng Dai

PHEOH

ONCOL

PRM

Chieh-Yang Cheng Taiwan

Yi Luan United States

Cam T. Ha United States

Dingqing Feng China

Zhengfeng Wang China

Pei‐Chen Hsu Taiwan

Qiu Tu China

Bray Denard United States

Zhengyu Li China

Wade M. Junker United States

Chieh-Yang Cheng Taiwan

Xiangpeng Dai

385 ×0.9

133 ×1.0

62 ×0.5

PHEOH

185 ×1.8

ONCOL

48 ×0.6

PRM

Citations per year, relative to Xiangpeng Dai Xiangpeng Dai (= 1×) peers Chieh-Yang Cheng

Countries citing papers authored by Xiangpeng Dai

Since Specialization

Citations

This map shows the geographic impact of Xiangpeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangpeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangpeng Dai more than expected).

Fields of papers citing papers by Xiangpeng Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangpeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangpeng Dai. The network helps show where Xiangpeng Dai may publish in the future.

Co-authorship network of co-authors of Xiangpeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangpeng Dai. A scholar is included among the top collaborators of Xiangpeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangpeng Dai. Xiangpeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yurong, Haibo Zhu, Fucheng Guo, et al.. (2025). Vitrification affects the post-implantation development of mouse embryos by inducing DNA damage and epigenetic modifications. Clinical Epigenetics. 17(1). 20–20. 1 indexed citations

Guo, Fucheng, et al.. (2024). Nicotinamide Mononucleotide improves oocyte maturation of mice with type 1 diabetes. Nutrition and Diabetes. 14(1). 23–23. 6 indexed citations

Zhang, Meng, Yanhui Zhai, Xinglan An, et al.. (2023). DNA methylation regulates RNA m⁶A modification through transcription factor SP1 during the development of porcine somatic cell nuclear transfer embryos. Cell Proliferation. 57(5). e13581–e13581. 9 indexed citations

Chen, Yurong, Luyao Wang, Fucheng Guo, Xiangpeng Dai, & Xiaoling Zhang. (2023). Epigenetic reprogramming during the maternal‐to‐zygotic transition. SHILAP Revista de lepidopterología. 4(4). e331–e331. 16 indexed citations

Zhang, Xin, Zheng Xu, Xiangpeng Dai, Xiaoling Zhang, & Xueju Wang. (2023). Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer. Frontiers in Immunology. 14. 1104860–1104860. 12 indexed citations

An, Xinglan, Cong Fu, Hao Yu, et al.. (2023). Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231. Frontiers in Bioscience-Landmark. 28(8). 186–186. 30 indexed citations

Gu, Xu, Yue Liu, Xiangpeng Dai, Yong‐Guang Yang, & Xiaoling Zhang. (2023). Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy. Frontiers in Immunology. 14. 1137107–1137107. 28 indexed citations

Li, Leyi, Qinghe Han, Yurong Chen, et al.. (2023). β-nicotinamide mononucleotide rescues the quality of aged oocyte and improves subsequent embryo development in pigs. PLoS ONE. 18(10). e0291640–e0291640. 8 indexed citations

Zhang, Xiaoying, Yue Liu, Tong Zhang, et al.. (2023). Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases. Frontiers in Immunology. 14. 1125224–1125224. 7 indexed citations

10.

Wang, Luyao, et al.. (2023). Current progress of pig models for liver cancer research. Biomedicine & Pharmacotherapy. 165. 115256–115256. 5 indexed citations

11.

Yang, Fan, et al.. (2023). The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Frontiers in Pharmacology. 14. 1143102–1143102. 32 indexed citations

12.

Wang, Ying, Longhui Zhang, Wenjie Zhao, et al.. (2022). Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN. Frontiers in Cell and Developmental Biology. 10. 1021820–1021820. 12 indexed citations

13.

Wang, Luyao, Yurong Chen, Xinrui Liu, Ziyi Li, & Xiangpeng Dai. (2022). The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems. Frontiers in Oncology. 11. 704999–704999. 24 indexed citations

14.

Zhang, Tong, Haixiang Yu, Xiangpeng Dai, & Xiaoling Zhang. (2022). CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment. Frontiers in Immunology. 13. 971428–971428. 12 indexed citations

15.

Deng, Mingtian, Yongjie Wan, Xiangpeng Dai, et al.. (2021). Long non-coding RNA lnc_3712 impedes nuclear reprogramming via repressing Kdm5b. Molecular Therapy — Nucleic Acids. 24. 54–66. 12 indexed citations

16.

An, Xinglan, Daoyu Zhang, Qi Li, et al.. (2021). Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(2). 119169–119169. 6 indexed citations

17.

Zhang, Meng, Sheng Zhang, Yanhui Zhai, et al.. (2021). Cycloleucine negatively regulates porcine oocyte maturation and embryo development by modulating N6-methyladenosine and histone modifications. Theriogenology. 179. 128–140. 9 indexed citations

18.

Zhu, Haibo, Hao Sun, Tianda Li, et al.. (2021). Transcriptome and DNA Methylation Profiles of Mouse Fetus and Placenta Generated by Round Spermatid Injection. Frontiers in Cell and Developmental Biology. 9. 632183–632183. 7 indexed citations

19.

Saferali, Aabida, Jeong H. Yun, Margaret M. Parker, et al.. (2019). Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene. PLoS Genetics. 15(7). e1008229–e1008229. 23 indexed citations

20.

Dai, Xiangpeng, Jie Hao, Xiaojun Hou, et al.. (2010). Somatic Nucleus Reprogramming Is Significantly Improved by m-Carboxycinnamic Acid Bishydroxamide, a Histone Deacetylase Inhibitor. Journal of Biological Chemistry. 285(40). 31002–31010. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact